I suppose Mr. Trump was reacting to the fire-hose of

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks SaltyMutt #141
120
Quote:
I suppose Mr. Trump was reacting to the fire-hose of objurgation aimed at him over the weekend on CNN by Carl Bernstein, reporter extraordinaire of Watergate fame, who referred to Trump’s sojourn in the Oval Office as “a malignant presidency.”

'Fire hose'? I saw it. Seemed to me rather objurcation delivered as precisely and thoroughly as though from a rotating ratcheting lawn sprinkler. LOL!

Isn’t comparing a person to cancer about as low as you can go? (You talkin’ to me???) That should technically entitle Mr. Trump to an inverted stomp face-breaker followed by a fall-away moonsault slam, topped off by a final gorilla drop. Hell, get the referee to sit on Bernstein’s face for the count.


You see more in Kunstler than I do. When I see him excoriate Fox News talking heads as he does A. Cooper, I'll see him in a different light.

Calling a presidency 'malignant' is well within acceptable metaphorical bounds when applied to institutions, as it was here.

And as it was when John Dean referred to the Watergate cover-up as a 'cancer on the presidency'.

A more careful and more objective opinion writer would have seen that from the actual words, and simply moved on past them.

Eisenhower 'punching out' E. R. Murrow? Really? I recall the latter doing that to' tail gunner' Joe McCarthy, deservedly, while Ike held his fire on that execrable demagogue.

And of course we never read of the 'deep state' when a Dem is president, except perhaps in the far less dark, non-pejorative, 'loyal
opposition', 'government in exile', sort of way.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

OnTime's Bold Vision: Transforming Home Healthcare Admin

Updated Category News Views 7

Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...

Continue Reading
Image Analysis Group Unveils DYNAMIKA V.7 for Clinical Trials

Updated Category News Views 185

Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....

Continue Reading
Sanofi's Strategic Move to Enhance Adult Vaccination Pipeline

Updated Category News Views 95

Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...

Continue Reading
Miral Impact Fund: A New Era for Community and Environment

Updated Category News Views 135

Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...

Continue Reading
Class Action Update for Regeneron Pharmaceuticals Investors

Updated Category News Views 125

Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...

Continue Reading